SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Direxion Shares ETF Trust - Direxion Daily S&P Biotech Bull 3X ETF

Direxion Daily S&P Biotech Bull 3X Shares

Biotech-sector strength and an XBI rebound are driving attention to LABU as a leveraged play on the group. Traders are split between expecting more momentum and warning of a pullback, with upcoming inflation data and rate expectations in focus for rate-sensitive biotech stocks.

Berkshire Hathaway, Inc. is a holding company, which engages in the provision of property and casualty insurance and reinsurance, utilities and energy, freight rail transportation, finance, manufacturing, and retailing services. It operates through the following segments: Insurance, Burlington Northern Santa Fe, LLC (BNSF), Berkshire Hathaway Energy (BHE), Pilot Travel Centers (PTC), Manufacturing, McLane, and Service and Retailing. The Insurance segment includes the underwriting of GEICO, Berkshire Hathaway Primary Group, and Berkshire Hathaway Reinsurance Group. The BNSF segment involves the operation of railroad systems. The BHE segment focuses on regulated electric and gas utility, power generation and distribution, and real estate brokerage activities. The PTC segment consists of managing travel centers and marketing of wholesale fuel. The Manufacturing segment refers to industrial, consumer and building products, home building, and related financial services. The McLane segment covers the wholesale distribution of groceries and non-food items. The Service and Retailing segment relates to the provision of shared aircraft ownership programs, aviation pilot training, electronic components distribution, retailing businesses, automobile dealerships and trailer, and furniture leasing services. The company was founded by Oliver Chace in 1839 and is headquartered in Omaha, NE.

Berkshire Hathaway Inc. - Ordinary Shares - Class B

Berkshires latest quarterly results drew attention for weaker operating performance, particularly in insurance, alongside a sharp increase in share repurchases. Traders are split between viewing the buybacks as a vote of confidence and worrying that softer insurance results and limited investment opportunities could weigh on the outlook.

Direxion Shares ETF Trust - Direxion Daily S&P Biotech Bear 3X ETF

Direxion Daily S&P Biotech Bear 3X Shares

LABD is drawing attention as biotech strength in XBI weighs on the 3x inverse fund, with traders pointing to Moderna-related momentum, acquisition activity and rotation into the sector. Bearish traders are positioning for a pullback, while others argue the rally remains strong and caution that LABDs leverage and daily decay make it difficult to hold through sustained gains in biotech.

Alcoa Corp. engages in the bauxite mining, alumina refining, and aluminum smelting and casting. It operates through the Alumina and Aluminum segments. The Alumina segment consists of a refining system, including the mining of bauxite, which is then refined into alumina, a compound of aluminum and oxygen that is the raw material used by smelters to produce aluminum metal. The Aluminum segment is composed of smelting and casthouse system. The company was founded by Charles Martin Hall on July 9, 1886 and is headquartered in Pittsburgh, PA.

Alcoa Corp

Alcoas earnings and aluminum-cycle outlook dominate the conversation: traders cite stronger-than-expected earnings and cash generation, while weighing softer revenue, costs, and cyclical downside risks. Discussion also points to the completed San Ciprin buyback and pending South32/AliGroup deal, with some seeing less joint-venture overhang and others focused on closing and commodity-price uncertainty.

Atlassian Corp. is a holding company, which engages in providing team collaboration and productivity software. Its products include Jira Software, Confluence, Jira Service Management, and Loom. The company was founded by Michael Cannon-Brookes and Scott Farquhar in October 2002 and is headquartered in San Francisco, CA.

Atlassian Corporation - Ordinary Shares - Class A

Atlassian Corporation Plc

Atlassian shares are sharply lower after earnings despite beating estimates, as traders focus on a much slower full-year growth outlook and weakness expected in its Data Center business. The selloff has fueled debate over whether cautious guidance and AI-related pressure on per-user software demand justify the reaction, or whether the strong quarter makes it an overreaction.

AstraZeneca Plc is a global, science-led biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines. Its portfolio spans oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory & immunology. The company was founded in 1913 and is headquartered in Cambridge, the United Kingdom.

Astrazeneca plc

AstraZeneca PLC

Reports of AstraZeneca making an acquisition offer for Rhythm Pharmaceuticals are driving attention, with traders weighing the potential expansion into rare metabolic and obesity treatments against uncertainty about whether a deal will proceed or attract other bidders. Some also debate whether AZN should pursue other obesity assets instead.

Roku, Inc. engages in the provision of a streaming platform for television. It operates through the following segments: Platform and Devices. The Platform segment includes the sale of digital advertising and distribution of streaming services. The Devices segment is involved in the sale of streaming players, Roku-made televisions, smart home products and services, audio products, and related accessories. The company was founded by Anthony J. Wood in October 2002 and is headquartered in San Jose, CA.

Roku Inc - Ordinary Shares - Class A

Roku Inc

Foxs acquisition of Roku has closed, ending ROKU as a standalone Nasdaq-listed company and shifting shareholders focus to the Fox shares and cash they receive. The community is marking the end of the ticker, with some celebrating their gains while others remain disappointed by the deals value and the loss of Rokus independent upside.

Revolution Medicines, Inc. is a clinical-stage precision oncology company, which engages in developing novel targeted therapies. It engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment regimens to maximize the depth and durability of clinical benefit and circumvent adaptive resistance mechanisms for patients which are dependent on the RAS and mTOR pathway. The company was founded by Mark A. Goldsmith, Kevan Shokat, Martin D. Burke, David L. Pompliano and Michael Fischbach in October 2014 and is headquartered in Redwood City, CA.

Revolution Medicines Inc

Attention centers on Revolution Medicines early RASONQUE launch and quarterly update, with traders highlighting rapid uptake and a strong commercial debut. The reaction is divided: some see the launch as evidence of major sales potential, while others worry about whether demand will persist and about high spending; recent buying and call-heavy options activity have added to the bullish chatter.

Algorand (ALGO) is a cryptocurrency launched in 2019. Algorand has a current supply of 10,000,000,000 with 9,078,194,480.417637 in circulation. The last known price of Algorand is 0.09693394 USD and is up 3.39 over the last 24 hours. It is currently trading on 586 active market(s) with $57,858,585.39 traded over the last 24 hours. More information can be found at http://algorand.foundation.

Algorand

Algorands prolonged underperformance and difficulty sustaining rebounds dominate the conversation, with bearish traders warning that rallies may fade and further losses could follow. Bulls counter with accumulation and an expected altcoin recovery, while some point to new leadership and quantum-security or tokenization themes as reasons for optimism.

Invesco DB US Dollar Index Bullish Fund - Invesco DB US Dollar Index Bullish Fund

Invesco DB US Dollar Index Bullish Fund

The U.S. dollars rebound around payroll data is driving attention, with traders linking its strength to Fed-rate expectations and Treasury yields. Some view a firmer dollar as pressure on gold and equities, while others question whether the advance can last amid longer-term dollar-weakness concerns.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


calculadora0

Calculadora Cientifica